Financials

Discussions Technicals Seasonals

322510 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

JLK, Inc. engages in the development of artificial intelligence-based stroke treatment solutions. It provides early diagnosis of diseases, assistance with reading, lesion detection, and prognosis prediction through medical imaging and clinical data analysis using artificial intelligence. The company was founded by Won-Tae Kim on February 18, 2014 and is headquartered in Cheongju-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

322510 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company